TCAS has provided toxicological guidance, written assessments and expert
testimony in hundreds of drug-related cases. Virtually all drugs of abuse are well-documented
in the peer-reviewed toxicological literature with clearly-established endpoints.
However, drugs of abuse are often taken in combination with alcohol or prescription
medications which can result in drug interactions and a variety of intensified reactions.
Drug abuse co-contaminants (such as contaminated needles and adulterants such as levamisole,
tetramisole, lidocaine, benzocaine, etc.) can also cause adverse health effects,
complicating the observed behavior or cause-of-death determination.
Historically, drugs identified in blood samples were reported quantitatively (amount)
while drugs identified in urine were typically reported qualitatively above a regulatory
cutoff level (e.g. "present" or "not detected"). Although such
immunoassays generally allow for rapid analyses, the results can vary in the range
of compounds detected; e.g. some detect specific drugs while others recognize only
certain classes of drugs.1
Today, most modern laboratories use both immunoassay and mass spectrometry
methods for drug analyses. These include Gas Chromatograph/Mass Spectrometry (GC/MS), Liquid Chromatography/Mass Spectrometry
(LC/MS), QTRAP Mass Spectrometry (also known as LC-Tandem/Mass Spectrometry or LC-MS/MS)
and/or Enzyme Immunosorbent Assay (EIA) instrumentation to detect and measure amounts
of drugs in blood, urine and other biological samples.
The increasing accuracy of antemortem
and postmortem biological sample analyses for illicit drugs and prescription medications
have correspondingly improved the accuracy and reliability of forensic drug testing.
These methods are increasingly viewed as viable investigative tools in cases ranging
from DUI to homicide investigations.
Show all results for "Benzodiazepines"
Benzodiazepines are a class of psychoactive drugs intended to treat anxiety, panic
attacks, depression, insomnia, seizures, nausea and other neurological conditions.
Although commonly prescribed, this class of medication presents significant toxicological
issues. Benzodiazepines have sedative, hypnotic, anxiolytic, anticonvulsant,
muscle relaxant and amnesic properties which work on the central nervous system and
which act selectively on gamma-aminobutyric acid-A (GABA-A) receptors in the brain.2 There are numerous generic formulations of benzodiazepines
including alprazolam (Xanax™), diazepam (Valium™), clonazepam (Klonopin™),
lorazepam (Ativan™), zolpidem (Ambien™) and others. Toxicity can be
significantly altered if combined with ethanol, opiates or tricyclic antidepressants.
TCAS has significant experience in assessing the toxic effects of benzodiazepines
on behalf of defendants and plaintiffs, singularly and in combination with other
contact our office for toxicological guidance relating to benzodiazepines.
Show all results for "Cocaine"
Cocaine toxicity occurs primarily in drug users but can also occur as a result of
accidental overdose when used as a local anesthetic or as a consequence of patient
hypersensitivity to cocaine alkaloids. The powdered form of cocaine is either inhaled
through the nose (where it is absorbed through nasal tissue) or dissolved in water
and injected directly into the bloodstream. "Crack" is a form of cocaine
that has been processed into a rock crystal that can be smoked. The crystal is heated
to produce vapors that are absorbed into the bloodstream through the lungs.3
Cocaine can cause excessive central nervous system stimulation and vasoconstriction
and can result in several hyper-stimulation toxicological endpoints including
hypertension, behavioral changes, organ ischemia and/or organ injury.
TCAS has performed many cocaine assessments in a variety of expert capacities.
recent cocaine assessment in our toxicological case studies illustrates
the importance of applying generally-accepted, peer-reviewed methods to drug screening
Show all results for "Morphine, Heroin, Methadone"
Opiates (morphine, heroin, methadone, codeine and others) belong to a class of naturally-occurring
alkaloids derived from the opium poppy plant. Opiates are distinguished colloquially
from opioids (see below) in that opioids are partly or wholly synthesized.
As a consequence of improper or over-dosage in non-tolerant individuals, respiratory
depression and death may result. Secondary effects can also occur due to adulterants
commonly found in illegal heroin and contaminated needles. The National Survey on
Drug Use and Health (NSDUH) has reported that there are presently more than
1 million "chronic heroin users" in the U.S.4
Toxicological effects include both short- and long-term endpoints stemming primarily
from excessive oral or intravenous use resulting in tolerance, increasing dosage
TCAS has substantial experience assessing the toxicological effects of
opiates, both singly and in combination with other pharmaceuticals. We have produced
numerous reports with respect to drug interactions and health effects and have provided
postmortem forensic evaluations with respect to drug alkaloid concentrations, causative
effects including additive effects, cause of death, correct disease identification
and other factors in many medical malpractice matters. Please contact our
office for additional information.
Show all results for "Opioids"
Opioids are a class of analgesic narcotics available only by prescription. Used
to treat moderate to severe pain, some opioids are also classified as drugs of abuse.
Opioids reduce the sending of pain messages to the brain by binding to opioid receptors
(μ-receptors) in the brain, spinal cord and other areas of the body. Opioids come in many forms
with many brand names. These include fentanyl (Actiq™, Duragesic™,
Fentora™), hydrocodone (Lorcet™, Lortab™, Norco™, Vicodin™),
hydromorphone (Dilaudid™, Exalgo™), meperidine (Demerol™), methadone
(Dolophine™, Methadose™), morphine (Avinza™, Kadian™, MS
Contin™, Ora-Morph SR™), oxycodone (OxyContin™, Oxyfast™,
Percocet™, Roxicodone™) and others.
TCAS has been regularly retained and has refuted or demonstrated causation based on objective
forensic evidence on behalf of both plaintiffs and defendants and has also provided
objective forensic evidence in federal criminal matters as well. Dr, Sawyer has assessed
the toxic effects of opioids in a variety of capacities both singularly and in combination
with other pharmaceuticals. Please
contact our office for additional information.
THC (Cannabis, Marijuana)
Show all results for "THC and Marijuana"
THC (delta 9-tetrahydrocannabinol) is the primary psychoactive constituent of cannabis
(marijuana). THC produces a variety of pharmacological effects in animals and humans.
One of the world's most widely abused substances, cannabis preparations are typically
smoked or ingested orally in foods. Acute exposures can lead to dependence and behavioral
disturbances. Heavy use may increase risk for psychotic disorders. THC can be
detected in the blood and other body fluids following exposure through active or passive
inhalation and exposure through breastfeeding. Accurate THC detection depends on
proper laboratory analytical procedures to detect and measure metabolites.
Many toxicological studies explore the mechanisms of action from pharmacokinetic
and pharmacodynamic standpoints. As the prevalence of recreational use of cannabis
continues to increase worldwide (particularly among young people) and in view of the
recent multi-state legislation permitting its limited use in the U.S., research on the chronic adverse effects
and retention of THC cannabinoids in human subjects is accelerating.5
A toxicological assessment of THC intoxication involves measured THC in samples (preferably with active and metabolite levels),
dosage and duration, timeframe, circumstances, bioavailability, limits of detection,
properties of the ingested cannabis and effects of other substances that may have
been concurrently ingested. Interestingly, more than 2,000 different compounds are
produced by pyrolysis during cannabis combustion.
TCAS has been been regularly retained by both defendants and plaintiffs
in a wide range of THC-related cases such as illustrated in a
recent case study. Please contact our
office for additional information.
Show all results for "Club Drugs"
"Club drugs" refer to a group of psychoactive drugs frequently abused
by young adults at concerts, all-night dance parties, dance clubs and bars.
The most common club drugs include Methylenedioxymethamphetamine (MDMA, also known
as Ecstasy), Gamma-hydroxybutyrate (GHB, also known as G, Liquid Ecstasy
and Soap), Ketamine (also known as Special K, Vitamin K and Jet),
Rohypnol (also known as Roofies), Methamphetamine (also known as Speed,
Ice, Crystal Meth and Crank) and Lysergic Acid Diethylamide
(LSD or acid).6
Although some of these drugs are approved for certain medical uses, they are most
commonly employed as drugs of abuse. All have profound toxicological effects and
can cause adverse health effects and sometimes death. Acting directly on the central
nervous system, these substances cause changes in mood, awareness and behavior and
are more dangerous when combined with alcohol or other drugs of abuse. Popular at
so-called "raves" and sometimes employed as "date rape" drugs,
the effects of these substances can (among other effects) reduce a person's ability
to resist an attack or sexual assault. Because some club drugs are colorless, odorless, and tasteless,
they can be added without detection to beverages by individuals who want to intoxicate
or sedate others.7
TCAS has significant experience assessing the toxicological effects of
club drugs. We have conducted numerous toxicological assessments, provided expert
testimony in "date rape" cases and produced reports with respect to drug interactions and health effects.
We have also provided postmortem forensic evaluations with respect to club drug
causative effects and toxicity in both forensic and criminal matters. Please
contact our office for additional information.
Notes and References
- California Academy of Family Physicians, "Urine Drug Testing in Clinical Practice," 2015
- National Center for Biotechnology Information, "GABA-A receptor subunits and benzodiazepine binding," British Journal of Biomededical Science, 2001;58(2):111-21.
- National Institute on Drug Abuse, "DrugFacts: Cocaine," National Institutes of Health, 2014.
- Office of National Drug Control Policy (ONDCP), "Heroin Facts and Figures," 2015
- U.S. National Library of Medicine, "Chemistry, Metabolism, and Toxicology of Cannabis," 2012
- U.S. National Library of Medicine, "Club Drugs," National Institutes of Health, 2014.
- Federal Bureau of Investigation, "Club Drugs," U.S. Department of Justice, 2015.
- Public domain thumbnail images courtesy www.scx.hu, photos by Ezran Kamal, "Rotorhead," Adam Ciesielski